Based on 28 analysts giving stock ratings to CVS Health Corp in the past month.
In the current month, CVS has received 18 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the last month is 112.248.
Based on analysts' estimates, CVS EPS is projected to reach 1.181 in FY2026Q4, following reported EPS of 1.694 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 1.69, while CVS Health CorpCVS's earnings per share (EPS) for the previous quarter was USD 2.33. EPS for the next quarter is expected at USD 1.18.